Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 121 - 150 of 254
<  Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
		European Medicines Agency's website: Rinvoq - EMA: EPAR PI Finnish Swedish
PL	Resepti	Risedronat Sandoz 35 mg tabletti, kalvopäällysteinen SPC 2021-07-08
PL	Resepti	Rismyl 0.5 mg, 1 mg, 2 mg tabletti, kalvopäällysteinen SPC 2023-03-29
PL	Resepti	Risperdal 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg tabletti, kalvopäällysteinen SPC 2022-03-14
PL	Resepti	Risperdal 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg tabletti, kalvopäällysteinen SPC 2022-03-14
PL	Resepti	Risperdal 1 mg-ml oraaliliuos SPC 2022-08-26
PL	Resepti	Risperdal Consta 25 mg, 37.5 mg, 50 mg injektiokuiva-aine ja liuotin, depotsuspensiota varten SPC 2021-11-11
PL	Resepti	Risperidon Actavis 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg tabletti SPC 2018-08-03
PL	Resepti	Risperidon Krka 0.5 mg, 1 mg, 2 mg tabletti, suussa hajoava SPC 2023-02-16
PL	Resepti	Risperidon Krka 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg tabletti, kalvopäällysteinen SPC 2023-02-16
PL	Resepti	Risperidon Orion 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg tabletti, kalvopäällysteinen SPC 2024-06-25
PL	Resepti	Risperidon Orion 1 mg-ml oraaliliuos SPC 2023-06-22
PL	Resepti	Risperidon ratiopharm 0.25 mg tabletti, kalvopäällysteinen SPC 2020-08-24
PL	Resepti	Risperidon Ratiopharm 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg tabletti, kalvopäällysteinen SPC 2023-06-06
PL	Resepti	Risperidon ratiopharm 25 mg, 37.5 mg, 50 mg injektiokuiva-aine ja liuotin, depotsuspensiota varten SPC 2021-12-17
PL	Resepti	Risperidon Sandoz 0.5 mg tabletti, kalvopäällysteinen SPC 2023-10-09
PL	Resepti	Risperidon Sandoz 1 mg, 2 mg, 3 mg, 4 mg tabletti, kalvopäällysteinen SPC 2023-10-09
PL	Resepti	Risperidon Sandoz 1 mg-ml oraaliliuos SPC 2023-10-06
PL	Resepti	Risperidone Grindeks 0,5 mg, 1 mg, 2 mg, 3 mg, 4 mg, 6 mg tabletti, kalvopäällysteinen SPC 2024-03-01.docx
PL	Resepti	Risperidone Stada 0.5 mg tabletti, kalvopäällysteinen SPC 2023-10-02
		European Medicines Agency's website: Ristaben - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Ristfor - EMA: EPAR PI Finnish Swedish
PL	Resepti	Ritonavir Accord 100 mg tabletti, kalvopäällysteinen SPC 2023-11-02
PL	Resepti	Ritonavir Sandoz 100 mg tabletti SPC 2020-05-06
		European Medicines Agency's website: Ritonavir Viatris (ent. Ritonavir Mylan) - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Rivaroxaban Accord - EMA: EPAR PI Finnish Swedish
PL	Resepti	Rivaroxaban Krka 10 mg tabletti, kalvopäällysteinen SPC 2024-03-13
PL	Resepti	Rivaroxaban Krka 15 mg tabletti, kalvopäällysteinen SPC 2024-03-13
PL	Resepti	Rivaroxaban Krka 2,5 mg tabletti, kalvopäällysteinen SPC 2024-03-13
PL	Resepti	Rivaroxaban Krka 20 mg tabletti, kalvopäällysteinen SPC 2024-03-13
<  Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >